Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
12.50
+0.02 (0.16%)
Aug 13, 2025, 4:00 PM - Market closed
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $2.17 billion as of August 14, 2025. Its market cap has increased by 71.88% in one year.
Market Cap
2.17B
Enterprise Value
1.86B
1-Year Change
71.88%
Ranking
Category
Stock Price
$12.50
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $2.17B, an increase of 704.04%. That is a compound annual growth rate of 20.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.17B | 61.99% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.11B |
| Johnson & Johnson | 415.17B |
| AbbVie | 350.24B |
| UnitedHealth Group | 236.46B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.39B |
| Novo Nordisk | 222.88B |